| 2.  | BP measured at least in 2 occasions 
                  prior to commencement of drug therapy |  | 90% |  | 110 | (31.5%) |  | 16 | (4.6%) |  | 223 (63.9%) | / | 
               
                |  | % of cases if unknown cases excluded |  |  |  |  | 87.3% |  |  | 12.7% |  |  |  | 
               
                | 3.  | Symptoms and signs of target organ damage 
                  assessed: |  | 90% |  |  |  |  |  |  |  |  |  | 
               
                |  | b. | left ventricular hypertrophy |  |  |  | 69 | (19.8%) |  | 280 | (80.2%) |  | / | / | 
               
                |  | f. | peripheral vascular disease |  |  |  | 26 | (7.4%) |  | 323 | (92.6%) |  | / | / | 
               
                | 4. | Risk factors for cardiovascular and 
                  cerebrovascular disease assessed |  | 90% |  |  |  |  |  |  |  |  |  | 
               
                |  | g. | family history of coronary artery disease |  |  |  | 343 | (98.3%) |  | 6 | (1.7%) |  | / | / | 
               
                | 5. | Pre-treatment BP > 140/90 |  | 90% |  | 125 | (35.8%) |  | 1 | (0.3%) |  | 223 (63.9%) | / | 
               
                |  | % of cases if unknown cases excluded |  |  |  |  | 99.2% |  |  | 0.8% |  |  |  | 
               
                | 6. | Patient reviewed at least every 6 months |  | 90% |  | 344 | (98.2%) |  | 5 | (1.4%) |  | / | / | 
               
                |   | b. | Blood pressure <130/80 for patients with diabetes 
                  or renal disease |  |  |  | 17 | (20%) |  | 67 | (80%) |  | / | / | 
               
                | 8.  | Patient referred for specialist advice |  | 90% |  | 4 | (1.1%) |  | 3 | (0.9%) |  | / | 342 (98%) | 
               
                |  | % if cases not indicated excluded |  |  |  |  | 57.1% |  |  | 42.9% |  |  |  | 
               
                | 9. | Side effects of drugs assessed annually |  | 80% |  | 275 | (78.8%) |  | 74 | (11.2%) |  | / | / | 
               
                | 10. | Diet advice given annually |  | 80% |  | 237 | (67.9%) |  | 112 | (22.1%) |  | / | / |